CAS: 1181226-02-7
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | 4-((3,5-Dichloro-2-hydroxybenzyl)amino)-2-hydroxybenzoic acid REF: IN-DA008TPQCAS: 1181226-02-7 | 98% | To inquire | Tue 21 Jan 25 |
 | ZL006 REF: TM-T17293CAS: 1181226-02-7 | 98.29% | 38.00 €~1,095.00 € | Mon 27 Jan 25 |
 | ZL006 REF: 3D-GXB22602CAS: 1181226-02-7 | Min. 95% | To inquire | Mon 03 Mar 25 |
4-((3,5-Dichloro-2-hydroxybenzyl)amino)-2-hydroxybenzoic acid
CAS:1181226-02-7
Formula:
C14H11Cl2NO4
Purity:
98%
Color and Shape:
Solid
Molecular weight:
328.1474
Ref: IN-DA008TPQ
| 5mg | 160.00 € | ||
| 10mg | 180.00 € | ||
| 25mg | 476.00 € | ||
| 50mg | 525.00 € | ||
| 100mg | To inquire | ||
| 250mg | To inquire |
Estimated delivery in United States, on Tuesday 21 Jan 2025
ZL006
CAS:1181226-02-7
ZL006 is an effective inhibitor of nNOS/PSD-95 interaction. ZL006 also inhibits NMDA receptor-mediated NO synthesis.
Formula:
C14H11Cl2NO4
Purity:
98.29%
Color and Shape:
Solid
Molecular weight:
328.15
Ref: TM-T17293
| 5mg | 52.00 € | ||
| 10mg | 68.00 € | ||
| 25mg | 118.00 € | ||
| 50mg | 181.00 € | ||
| 100mg | 309.00 € | ||
| 200mg | 446.00 € | ||
| 1mL*10mM (DMSO) | 53.00 € |
Estimated delivery in United States, on Monday 27 Jan 2025
ZL006
CAS:1181226-02-7
ZL006 is a potential drug target that has been shown to inhibit the activity of …
Formula:
C14H11Cl2NO4
Purity:
Min. 95%
Molecular weight:
328.15 g/mol
Ref: 3D-GXB22602
| 50mg | 1,084.00 € | ||
| 100mg | 1,508.00 € |
Estimated delivery in United States, on Monday 3 Mar 2025
